Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Research Square
|
February 6, 2026
Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep Learning
Abdul Rehman Akbar, Alejandro Levya, Ashwini Esnakula, et al.
Annals of Hepato-Biliary-Pancreatic Surgery
|
January 27, 2026
Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Database
McKenzie L Schaefer, Patrick L Quinn, Alexander H Shannon, et al.
Gastroenterology Research
|
January 13, 2025
Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint Inhibitors
Ashish Manne, Fode Tounkara, Eric Min, et al.
Frontiers in Oncology
|
April 22, 2025
Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights
Ashish Manne, Yonghua Bao, Ankur Sheel, et al.
Translational Oncology
|
July 5, 2025
Differential gene expression profiles of pancreatic ductal adenocarcinomas among African American and Caucasian American patients
Prachi Bajpai, Ravi Paluri, Sameer Al Diffalha, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 14, 2025
Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis
Patrick W Underwood, Thomas Leuschner, Amanda K Walsh, et al.
Gastroenterology Research
|
November 10, 2025
Risk Stratification and Contemporary Predictors of Survival in Hepatocellular Carcinoma Treated With Transarterial Radioembolization
Deepak Sherpally, Parthib Das, Fode Tounkara, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 11, 2024
Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
Prachi Bajpai, Sumit Agarwal, Farrukh Afaq, et al.
Journal of Cancer Research and Therapeutics
|
October 3, 2023
The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival
Ashish Manne, Madhuri Mulekar, Daisy Escobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
Chunjie Li, Anne M Noonan, John Hays, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Research Square
|
February 6, 2026
Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep Learning
Abdul Rehman Akbar, Alejandro Levya, Ashwini Esnakula, et al.
Annals of Hepato-Biliary-Pancreatic Surgery
|
January 27, 2026
Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Database
McKenzie L Schaefer, Patrick L Quinn, Alexander H Shannon, et al.
Gastroenterology Research
|
January 13, 2025
Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint Inhibitors
Ashish Manne, Fode Tounkara, Eric Min, et al.
Frontiers in Oncology
|
April 22, 2025
Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights
Ashish Manne, Yonghua Bao, Ankur Sheel, et al.
Translational Oncology
|
July 5, 2025
Differential gene expression profiles of pancreatic ductal adenocarcinomas among African American and Caucasian American patients
Prachi Bajpai, Ravi Paluri, Sameer Al Diffalha, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 14, 2025
Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis
Patrick W Underwood, Thomas Leuschner, Amanda K Walsh, et al.
Gastroenterology Research
|
November 10, 2025
Risk Stratification and Contemporary Predictors of Survival in Hepatocellular Carcinoma Treated With Transarterial Radioembolization
Deepak Sherpally, Parthib Das, Fode Tounkara, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 11, 2024
Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
Prachi Bajpai, Sumit Agarwal, Farrukh Afaq, et al.
Journal of Cancer Research and Therapeutics
|
October 3, 2023
The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival
Ashish Manne, Madhuri Mulekar, Daisy Escobar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial
Chunjie Li, Anne M Noonan, John Hays, et al.
Page
of 6